Importance Systemic amyloidosis from transthyretin (ATTR) protein is the most common type
of amyloidosis that causes cardiomyopathy. Observations Transthyretin (TTR) protein …

Cardiac amyloidosis (CA) is a restrictive disease that results from intramyocardial amyloid
deposition due to immunoglobulin light chain or transthyretin proteins. Up to two-third of CA …

Aims Although systemic embolism is a potential complication in transthyretin amyloid
cardiomyopathy (ATTR‐CM), data about its incidence and prevalence are scarce. We …

Tafamidis is the only therapy shown to improve survival in transthyretin cardiac amyloidosis
(ATTR) based on randomized controlled trial data. We sought to evaluate the impact of …

Cardiac amyloidosis is caused by amyloid fibrils that deposit in the myocardial interstitium,
causing restrictive cardiomyopathy and eventually death. The electromechanical …

Cardiac amyloidosis represents a spectrum of conditions characterized by the accumulation
of insoluble fibrils, resulting in progressive deposition and myocardial dysfunction. The exact …

Cardiac amyloidosis is the most frequent infiltrative disease caused by the deposition of
misfolded proteins in the cardiac tissue, leading to heart failure, brady-and tachyarrhythmia …

Introduction Both atrial fibrillation (AF) and amyloidosis increase stroke risk. We evaluated
the best anticoagulation strategy in AF patients with coexistent amyloidosis. Methods …

A 69-year-old female presented with symptomatic atrial fibrillation. Cardiac amyloidosis was
suspected due to an artificial intelligence clinical tool applied to the presenting …

Background We recently demonstrated that patients with atrial fibrillation (AF) and
hypertrophic cardiomyopathy (HCM) have an increased risk of left atrial (LA) thrombus. In …